Immunovant to Present at Roivant Investor Day on September 28th

September 21, 2022

https://www.globenewswire.com/news-release/2022/09/21/2520113/0/en/Immunovant-to-Present-at-Roivant-Investor-Day-on-September-28th.html

NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq:IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for people with autoimmune diseases, today announced that Pete Salzmann, M.D., Chief Executive Officer, will present a corporate update at Roivant’s Investor Day, taking place on September 28th, 2022.

Read more at globenewswire.com

Related news for (IMVT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.